Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel® in the treatment of irritable bowel syndrome with diarrhoea (IBS-D) in adults

Peer Review reports

Original Submission
6 Jun 2019	Submitted	Original manuscript
23 Sep 2019	Reviewed	Reviewer Report - Amit Goel
10 Nov 2019	Reviewed	Reviewer Report - Bo Kong
25 Dec 2019	Author responded	Author comments - Anu Kemppinen
Resubmission - Version 2
25 Dec 2019	Submitted	Manuscript version 2
6 Jan 2020	Reviewed	Reviewer Report - Amit Goel
11 Jan 2020	Reviewed	Reviewer Report - Bo Kong
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
13 Jan 2020	Editorially accepted
30 Jan 2020	Article published	10.1186/s13063-020-4069-x

Back to article page